Tachyon Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Tachyon Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer (NCT05076552) | Tachyon Therapeutics, Inc. | 2023-02-17 |
Track Tachyon Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.